Company intelligence / Profile preview

Maxine

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Maxine is a digital health company that provides an AI-powered health platform designed to create a "digital twin" of the human body. By integrating data from blood tests, wearable devices, and medical history, the platform simulates physiological responses to help users optimize their health and longevity. The company focuses on preventative care, offering personalized insights into metabolic, cardiovascular, and hormonal health. Maxine's technology aims to shift healthcare from a reactive model to a proactive, data-driven approach by predicting future health outcomes and recommending targeted interventions.

Therapeutic areas: CardiovascularMetabolic DisordersOther
Modalities: Digital TwinArtificial IntelligenceSoftware as a Medical Device
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Maxine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maxine.

Explore the full profile